Literature DB >> 11428917

Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance.

C A Hrycyna1.   

Abstract

A variety of human cancers become resistant or are intrinsically resistant to treatment with conventional drug therapies. This phenomenon is due in large part to the overexpression of a 170 kDa plasma membrane ATP-dependent pump known as the multidrug resistance transporter or P-glycoprotein. P-glycoprotein is a member of the large ATP binding cassette (ABC) superfamily of membrane transporters. This review focuses on the use of structure-function analyses to elucidate further the mechanism of action of mammalian P-glycoproteins. Ultimately, a complete understanding of the mechanism is important for the development of novel strategies for the treatment of many human cancers. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11428917     DOI: 10.1006/scdb.2000.0250

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  10 in total

1.  Dynamics of a bacterial multidrug ABC transporter in the inward- and outward-facing conformations.

Authors:  Shahid Mehmood; Carmen Domene; Eric Forest; Jean-Michel Jault
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

2.  The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells.

Authors:  Thuy Thanh Tran; Aditya Mittal; Tanya Aldinger; Joseph W Polli; Andrew Ayrton; Harma Ellens; Joe Bentz
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

3.  Toward eradicating HIV reservoirs in the brain: inhibiting P-glycoprotein at the blood-brain barrier with prodrug abacavir dimers.

Authors:  Hilda A Namanja; Dana Emmert; David A Davis; Christopher Campos; David S Miller; Christine A Hrycyna; Jean Chmielewski
Journal:  J Am Chem Soc       Date:  2011-09-09       Impact factor: 15.419

4.  Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.

Authors:  Dana Emmert; Christopher R Campos; David Ward; Peihua Lu; Hilda A Namanja; Kelsey Bohn; David S Miller; Frances J Sharom; Jean Chmielewski; Christine A Hrycyna
Journal:  ACS Chem Neurosci       Date:  2014-02-07       Impact factor: 4.418

Review 5.  Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux.

Authors:  T W Loo; D M Clarke
Journal:  J Membr Biol       Date:  2005-08       Impact factor: 1.843

6.  Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers.

Authors:  Marcos M Pires; Dana Emmert; Christine A Hrycyna; Jean Chmielewski
Journal:  Mol Pharmacol       Date:  2008-10-22       Impact factor: 4.436

7.  Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer.

Authors:  Hilda A Namanja; Dana Emmert; Marcos M Pires; Christine A Hrycyna; Jean Chmielewski
Journal:  Biochem Biophys Res Commun       Date:  2009-08-14       Impact factor: 3.575

8.  Exhaustive sampling of docking poses reveals binding hypotheses for propafenone type inhibitors of P-glycoprotein.

Authors:  Freya Klepsch; Peter Chiba; Gerhard F Ecker
Journal:  PLoS Comput Biol       Date:  2011-05-12       Impact factor: 4.475

9.  Changes in P-glycoprotein activity are mediated by the growth of a tumour cell line as multicellular spheroids.

Authors:  Valeria Ponce de León; Raúl Barrera-Rodríguez
Journal:  Cancer Cell Int       Date:  2005-07-07       Impact factor: 5.722

10.  The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors.

Authors:  Jason Goebel; Jean Chmielewski; Christine A Hrycyna
Journal:  Cancer Drug Resist       Date:  2021-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.